Artificial-intelligence evangelists such as Sam Altman want to reshape the world, but they need mountains of money to do it. That is sparking a modern-day gold rush on Wall Street.

There is no word yet on when the IPO will happen. According to Voyager, it is still working out "the number of shares to be ...

Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.

Private equity will have a more positive 2025 than it's had recent years, and institutional investors will likely turn their ...

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

BloombergNEF says in a new report that global clean energy investment reached $2.1 trillion in 2024, more than doubling 2020 ...

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...

A report on energy transition investments from BloombergNEF showed that global investment in clean energy technologies hit a ...

Shares in Venture Global are expected to make their debut on the New York Stock Exchange after the company raised $1.75 ...

Oilfield services provider Baker Hughes said on Thursday it has signed an agreement with Venture Global to support its ...

Taking yet another step in its preparations for its IPO, B2B marketplace unicorn OfBusiness has converted itself into a ...

A federal inspection report released on Wednesday said that Venture Global LNG may be able to complete power generator repairs before the end of the month.